Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Liver transplantation offers live-saving therapy for patients with complications of cirrhosis
and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and …

OBJECTIVES: Chronic infection with hepatitis C virus (HCV) was previously the leading
indication for liver transplant (LT) in the United States. However, since 2014 the use of direct …

Muscle depletion or sarcopenia is associated with increased mortality in patients with
cirrhosis; how it affects mortality after liver transplantation requires further study. In this study …

Background & Aims There are conflicting data regarding the epidemiology of hepatocellular
carcinoma (HCC) arising in the context of non-alcoholic and metabolic-associated fatty liver …

Background Sex-based disparities in liver transplantation (LT) are incompletely understood.
We assessed the role of height, Model for End-Stage Liver Disease (MELD), MELD-Na, and …

Organ transplantation as an option to overcome end-stage diseases is common in countries
with advanced healthcare systems and is increasingly provided in emerging and develo** …

Summary Background The Model for End-stage Liver Disease (MELD) and its sodium-
corrected variant (MELD-Na) have created gender disparities in accessing liver …

In this review article, we discuss the model for end-stage liver disease (MELD) score and its
dual purpose in general and transplant hepatology. As the landscape of liver disease and …

Model for end-stage liver disease (MELD) score, initially developed to predict survival
following transjugular intrahepatic portosystemic shunt was subsequently found to be …